ArticleTherapeutic advances in urology2010
Medical evaluation and management of urolithiasis.
Article in Therapeutic advances in urology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Outcomes and Complications from a Randomized Controlled Study Comparing Conventional Stent Placement Versus No Stent Placement after Ureteroscopy for Distal Ureteric Calculus < 1 cmJournal of clinical medicine · 2022Article
- Biochemical and molecular effects of a commercial diuretic with herbal extract on experimentally induced urolithiasis in chickens.Veterinary research communications · 2022Article
- Antioxidant and Polyphenol-Rich Ethanolic Extract ofMolecules (Basel, Switzerland) · 2021Article
- Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial.Arab journal of urology · 2020Article
- Predictive Factors for Achieving the Recommended AUA Daily Urine Production in Patients With Nephrolithiasis.Mayo Clinic proceedings. Innovations, quality & outcomes · 2019Article
- Detector-based spectral CT with a novel dual-layer technology: principles and applications.Insights into imaging · 2017Review
- Protective effect of ethyl acetate fraction ofJournal of traditional and complementary medicine · 2017Article
- Effects of commercial citrate-containing juices on urolithiasis in a Drosophila model.The Kaohsiung journal of medical sciences · 2013Article
- Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones.Urolithiasis · 2013Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nephrolithiasis is a highly prevalent condition with a high recurrence rate that has a large impact on the quality of life of those affected. It also poses a great financial burden on society. There have been great advancements in the surgical treatment of stone disease over the past several decades. The evolution of surgical technique appears to have overshadowed the importance of prevention of stone disease despite evidence showing medical therapies significantly decreasing stone recurrence rates. Herein we review the metabolic evaluation of stone formers with the use of specific blood and urine tests. We complete our discussion with a review of the medical management of stone formers providing both general recommendations as well as reviewing focused therapies for specific metabolic abnormalities and medical conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.